Finance

Lists
Why is SVNS up 7.14%?
Dive Deeper
SVNS:LON
Solvonis Therapeutics PLC
GBX 0.12
+7.14%
(+0.0080) 1D
Oct 2, 4:46:48 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for SVNS...
Open
GBX 0.10
High
GBX 0.12
Low
GBX 0.10
Mkt. cap
9.65M
Avg. vol.
22.83M
Volume
76.59M
52-wk high
GBX 0.40
52-wk low
GBX 0.10
EPS
-GBX 0.00
Shares outstanding
7.90B
No. of employees
6
Open
GBX 0.10
High
GBX 0.12
Low
GBX 0.10
Mkt. cap
9.65M
Avg. vol.
22.83M
Volume
76.59M
52-wk high
GBX 0.40
52-wk low
GBX 0.10
EPS
-GBX 0.00
Shares outstanding
7.90B
No. of employees
6
News stories
From web sources and news partners
About Solvonis Therapeutics PLC
CEO-
Employees6
Founded2017
Headquarters-
SectorBiotechnology
Websitesolvonis.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
808.50K
808.50K
699.50K
699.50K
Operating expense
808.50K
808.50K
979.00K
979.00K
Total operating expenses
808.50K
808.50K
979.00K
979.00K
Operating income
-808.50K
-808.50K
-979.00K
-979.00K
Other non operating income
-
-
-
-
EBT including unusual items
-810.50K
-810.50K
-2.06M
-2.06M
EBT excluding unusual items
-810.50K
-810.50K
-928.00K
-928.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-810.50K
-810.50K
-2.06M
-2.06M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
2.00K
2.00K
Interest expense
-2.00K
-2.00K
-
-
Net interest expenses
-2.00K
-2.00K
2.00K
2.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps